By Rebekah Devorak | Opinions Editor If you were holding the difference between life and death for someone in your hands, what would you do? If you’re Martin Shkreli, you’ll let them live – but only if they are able to fork up a ridiculous amount of money first. This is currently the case at the Turing Pharmaceuticals company, of which Shkreli is CEO. Recently … Continue reading Shkreli wrong to raise Daraprim price